Results 11 to 20 of about 803,874 (212)

Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity [PDF]

Journal of Lipid Research, 2013
It is important to understand HDL heterogeneity because various subspecies possess different functionalities. To understand the origins of HDL heterogeneity arising from the existence of particles containing only apoA-I (LpA-I) and particles containing ...
Eric T. Alexander, Michael C. Phillips
doaj   +3 more sources

Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease [PDF]

Lipids in Health and Disease, 2012
Background Visceral fat possesses the most detrimental potential for cardiovascular morbidity through the release of adipokines, as well as metabolic and proinflammatory mediators, which adversely affect metabolic and vascular homeostasis.
Perelas Apostolos, Safarika Vanessa, Vlachos Ioannis S, Tzanetakou Irene, Korou Laskarina-Maria, Konstantopoulos Panagiotis, Doulamis Ilias, Ioannidis Ioannis, Kornezos Ioannis, Gargas Dimitrios, Klonaris Christos, Perrea Despina N, Chatziioannou Achilleas   +12 more
doaj   +2 more sources

Human apolipoprotein A-I and A-II metabolism

Journal of Lipid Research, 1982
The kinetics of the major apolipoproteins (apo) of plasma high density lipoproteins (HDL), apoA-I and apoA-II, were examined in a total of 44 individual tracer studies in 22 normal male and female subjects.
E J Schaefer, L A Zech, L L Jenkins, T J Bronzert, E A Rubalcaba, F T Lindgren, R L Aamodt, H B Brewer, Jr   +7 more
doaj   +3 more sources

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis [PDF]

Case Reports in Nephrology, 2016
Hereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light ...
Sadichhya Lohani, Emily Schuiteman, Lohit Garg, Dhiraj Yadav, Sami Zarouk   +4 more
doaj   +2 more sources

Immunonephelometry of apolipoprotein A-II in plasma.

Clinical Chemistry, 1984
Abstract A quantitative assay based on endpoint immunonephelometry was developed for human apolipoprotein A-II (apoA-II) in plasma or serum. Dilution of plasma samples with a 0.1 mol/L solution of sodium cholate enhanced the quantification. We used either purified apoA-II as the primary standard or plasma as a secondary standard. Results
M. Rosseneu, N. Vinaimont, T. Musliner, D. Bernier, P. Herbert, F. Belpaire   +5 more
semanticscholar   +3 more sources

Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects [PDF]

, 2010
Background - Biomarkers that allow detection of the onset of disease are of high interest since early detection would allow intervening with lifestyle and nutritional changes before the disease is manifested and pharmacological therapy is required.
A. Geert Heidema, Edith J. M. Feskens, Johanna M. Geleijnse, Lisette C. P. G. M. de Groot, Lydia A. Afman, Marieke B. Bos, Michael Müller, Ondine van de Rest, Susan J. van Dijk   +8 more
core   +16 more sources

Turbidimetric Assay of Apolipoprotein A-II [PDF]

Clinical Chemistry and Laboratory Medicine, 1985
A turbidimetric assay for the quantification of apolipoprotein A-II in serum is described. Its adaptation for the Cobas Bio Analyser (Hoffmann La Roche) is reported. Regression analysis of apolipoprotein A-II values measured by turbidimetry revealed a good measure of agreement with the data obtained by radial immunodiffusion (RID) (r = 0.90, y = 0.97x +
Schriewer, H., Emke, F., Assmann, G.
openaire   +3 more sources

Radioimmunoassay of apolipoprotein a-ii. [PDF]

Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982
A double antibody radioimmunoassay was developed for apolipoprotein A-II (apo A-II), one of the two major apoproteins of human high density lipoproteins (HDL). Apo A-II contains two identical polypeptide chains linked by a disulfide bond. A specific antiserum was raised in sheep. Tracer apo A-II was radiolabeled with 125I by the Bolton-Hunter technique.
T A, Musliner, P A, Garner, L O, Henderson, P N, Herbert   +3 more
openaire   +2 more sources

Competitive Enzyme Immunoassay for Apolipoprotein A-II [PDF]

cclm, 1983
A competitive enzyme immunoassay for apolipoprotein A-II was developed. Microtitre plates were used as a solid phase and coated with anti-apolipoprotein A-II antibodies. Purified apolipoprotein A-II, labelled with horseradish peroxidase was used as competing ligand.
Dufaux, B., Ilsemann, K., Assmann, G.
openaire   +3 more sources

Apolipoprotein A-II [PDF]

Circulation Research, 2003
Familial combined hyperlipidemia (FCH) was originally identified as a new phenotype in studies of survivors of myocardial infarctions and their relatives.1–3 Patients with FCH were found to present with any of three patterns of lipoprotein distribution: elevated plasma levels of very low-density lipoprotein (VLDL) or low-density lipoprotein (LDL) or ...
Bradley E, Aouizerat, John P, Kane
openaire   +2 more sources